Optimizing management of the elderly patient with glioblastoma: Survival prediction online tool based on BC Cancer Registry real-world data

Author:

Zhao Rachel1,Zeng Jonathan1,DeVries Kimberly2,Proulx Ryan3,Krauze Andra Valentina14

Affiliation:

1. University of British Columbia, Faculty of Medicine , Vancouver, British Columbia , Canada

2. Cancer Surveillance & Outcomes, BC Cancer , Vancouver, British Columbia , Canada

3. Safe Software , Surrey, British Columbia , Canada

4. Radiation Oncology Branch, National Cancer Institute , Bethesda, Maryland , USA

Abstract

Abstract Background Glioblastoma (GBM) is associated with fatal outcomes and devastating neurological presentations especially impacting the elderly. Management remains controversial and representation in clinical trials poor. We generated 2 nomograms and a clinical decision making web tool using real-world data. Methods Patients ≥60 years of age with histologically confirmed GBM (ICD-O-3 histology codes 9440/3, 9441/3, and 9442/3) diagnosed 2005–2015 were identified from the BC Cancer Registry (n = 822). Seven hundred and twenty-nine patients for which performance status was captured were included in the analysis. Age, performance and resection status, administration of radiation therapy (RT), and chemotherapy were reviewed. Nomograms predicting 6- and 12-month overall survival (OS) probability were developed using Cox proportional hazards regression internally validated by c-index. A web tool powered by JavaScript was developed to calculate the survival probability. Results Median OS was 6.6 months (95% confidence interval [CI] 6–7.2 months). Management involved concurrent chemoradiation (34%), RT alone (42%), and chemo alone (2.3%). Twenty-one percent of patients did not receive treatment beyond surgical intervention. Age, performance status, extent of resection, chemotherapy, and RT administration were all significant independent predictors of OS. Patients <80 years old who received RT had a significant survival advantage, regardless of extent of resection (hazard ratio range from 0.22 to 0.60, CI 0.15–0.95). A nomogram was constructed from all 729 patients (Harrell’s Concordance Index = 0.78 [CI 0.71–0.84]) with a second nomogram based on subgroup analysis of the 452 patients who underwent RT (Harrell’s Concordance Index = 0.81 [CI 0.70–0.90]). An online calculator based on both nomograms was generated for clinical use. Conclusions Two nomograms and accompanying web tool incorporating commonly captured clinical features were generated based on real-world data to optimize decision making in the clinic.

Funder

Porte-Hungerford Neuro-Oncology Grant

BC Cancer Summer Studentship Program.

Publisher

Oxford University Press (OUP)

Subject

Electrical and Electronic Engineering,Building and Construction

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3